Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers.

To identify new biomarkers that improve the early diagnosis and lead to possible therapeutic targets in pancreatic carcinoma, we performed a proteomic approach to compare serum protein expression patterns of pancreatic carcinoma patients with that of gastric cancer patients, other pancreatic disease patients, and healthy volunteers. By two-dimensional gel electrophoresis (2-DE) analyses and mass spectroscopic identification, 10 protein spots were found significantly changed in pancreatic carcinoma and 5 proteins including cyclin I, Rab GDP dissociation inhibitor beta (GDI2), alpha-1 antitrypsin precursor, Haptoglobin precursor, and Serotransferrin precursor were successfully identified. The increased levels of cyclin I and GDI2 found to be associated with pancreatic carcinoma were further confirmed by Western blot analyses in an independent series of serum samples and/or pancreatic juice samples. Applying immunohistochemistry, we further validated expression of cyclin I and GDI2 in additional pancreatic carcinomas. These results indicate that cyclin I and GDI2 may be potential molecular targets for pancreatic cancer diagnostics and therapeutics.

[1]  Xuejiang Guo,et al.  Proteomic analysis of effect of hyperthermia on spermatogenesis in adult male mice. , 2006, Journal of proteome research.

[2]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[3]  Peng-Yuan Yang,et al.  Heat‐shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis , 2005, Proteomics.

[4]  Ruedi Aebersold,et al.  Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery* , 2005, Molecular & Cellular Proteomics.

[5]  A. Seth,et al.  Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. , 2003, Anticancer research.

[6]  Wendy Frankel,et al.  Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. , 2006, Cancer research.

[7]  Kevin R Coombes,et al.  Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  K. Jirström,et al.  Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression , 2005, Breast Cancer Research and Treatment.

[9]  M. Oishi,et al.  Cyclin I: a new cyclin encoded by a gene isolated from human brain. , 1995, Experimental cell research.

[10]  K. Baggerly,et al.  Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting. , 2005, Rapid communications in mass spectrometry : RCM.

[11]  R. Erdman,et al.  Different Rab GTPases Associate Preferentially with α or β GDP-Dissociation Inhibitors , 2001 .

[12]  A. Rustgi,et al.  Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. , 2005, Journal of proteome research.

[13]  James L. Abbruzzese,et al.  Protein Expression Profiles in Pancreatic Adenocarcinoma Compared with Normal Pancreatic Tissue and Tissue Affected by Pancreatitis as Detected by Two-Dimensional Gel Electrophoresis and Mass Spectrometry , 2004, Cancer Research.

[14]  Nuzhat Ahmed,et al.  Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer , 2005, Proteomics.

[15]  D. Lombardo,et al.  Impairment of bile salt‐dependent lipase secretion in human pancreatic tumoral SOJ‐6 cells , 2000, Journal of cellular biochemistry.

[16]  R. Hruban,et al.  Can we screen high‐risk individuals to detect early pancreatic carcinoma? , 2000, Journal of surgical oncology.

[17]  Tesshi Yamada,et al.  Serum tumor markers for pancreatic cancer: the dawn of new era? , 2006, JOP : Journal of the pancreas.

[18]  K. Lillemoe,et al.  Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. , 2002, Cancer research.

[19]  Xiaozhong Guo,et al.  Current diagnosis and treatment of pancreatic cancer in China. , 2005, Pancreas.

[20]  S. Hanash,et al.  Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. , 2006, Gastroenterology.

[21]  Emilio Marengo,et al.  Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis , 2004, Analytical and bioanalytical chemistry.

[22]  James M. Roberts,et al.  Cyclin I Protects Podocytes from Apoptosis* , 2006, Journal of Biological Chemistry.